Jump to content

Dutchmuch, karma has caught up with Shkreli


glutes
This topic is 865 days old and is no longer open for new replies.  Replies are automatically disabled after two years of inactivity.  Please create a new topic instead of posting here.  

Recommended Posts

image.thumb.png.e327cdf7d3f5dffa42c38a06f8a5af13.png

 

Jan. 14, 2022, 12:23 PM PST
By David K. Li / NBC News

Disgraced drug company executive Martin Shkreli, derided as the “Pharma Bro,” was banned from ever doing business again in the pharmaceutical business, a judge ordered on Friday.

Shkreli was also ordered to pay $64.6 million in profits he scored from hiking the price of the drug Daraprim, U.S. District Court Judge Denise Cote ruled in New York.

 

The court order is tied to a lawsuit, filed by the Federal Trade Commission and several states, including New York and California, that accused the imprisoned Shkreli of monopolistic behavior.

 

As CEO of Turing Pharmaceuticals — later Vyera — Shkreli inflated the price of Daraprim from $13.50 to $750 per pill, after obtaining exclusive rights to the decades-old drug in 2015. Daraprim is needed by those suffering from a rare parasitic disease that strikes AIDS patients, cancer victims and pregnant women.

Edited by glutes
Link to comment
Share on other sites

  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...